• Image of S/Uni Duo blend (Sunifiram-15mg) (Unifiram-5mg)


Sunifiram is a powerful AMPAkine(targets mainly AMPA(and NMDA to a degree) receptors, 2 of 3 main subsets of glutamate receptors) and is a synthetically altered semi-derivative of the proto-noot, Piracetam.  Despite being a newer compound and having limited human research, preliminary reports have shown Sunifiram to postively effect LTP(long-term potentiation) levels in the hippocampus, which increases synaptic plasticity, long term, meaning it tunes synapses' individual wavelengths to their neighbors when used, enhancing their signal transmission and pathways, leading to increased memory retention and perceptual sensory data absorption. It also aids in the release of acetylcholine in the prefrontal cortex up to 200%, and has been shown to increase sensitivity to stims(including caffeine and finils), making stacking them oftentimes unnecessary and undesirable.  It also noticeably increases dream realism.

Unifiram is a newer compound very similar in structure to Sunifiram, but the synthesizing process is much more difficult and costly. Differences include a slightly smaller necessary dosage, and in-vitro studies have shown it to increase the amplitude of fEPSP(field excitatory postsynaptic potential) in the hippocampus of mice, meaning it essentially increases the overall power output in the brains neural field, strengthening the signals and increasing their firing speed farther than Suni's LTP-tuning effects.